ETC-159
| CAS No. | 1638250-96-0 | Cat. No. | BCP20688 |
| Name | ETC-159 | ||
| Synonyms | ETC159; ETC 159; ETC-1922159; ETC 1922159; ETC1922159; | ||
| Formula | C19H17N7O3 | M. Wt | 391.38 |
| Description | ETC-159, also known as ETC-1922159, is a potent, selective and orally available PORCN inhibitor. ETC-159 blocks the secretion and activity of all Wnts. ETC-159 is remarkably effective in treating RSPO-translocation bearing colorectal cancer (CRC) patient-derived xenografts. Inhibition of Wnt signaling by PORCN inhibition holds promise as differentiation therapy in genetically defined human cancers. Enhanced sensitivity to Wnts is an emerging hallmark of a subset of cancers, defined in part by mutations regulating the abundance of their receptors. | ||
| Pathways | Wnt/Stem Cell | ||
| Targets | Wnt | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.